Posted by Michael Wonder on 03 Sep 2018
Britain loses medicines contracts as EU body anticipates Brexit
3 September 2018 - European Medicines Agency ends pharma evaluations work and moves contracts to bloc.
Britain’s leading role in evaluating new medicines for sale to patients across the EU has collapsed with no more work coming from Europe because of Brexit, it has emerged.
The decision by the European Medicines Agency to cut Britain out of its contracts seven months ahead of Brexit is a devastating blow to British pharmaceutical companies already reeling from the loss of the EMA’s HQ in London and with it 900 jobs.
